INSIGHTS ON SOLID DOSE MANUFACTURING

• The Future Of Sustainable Amorphous Dispersion Development

  Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.

• Layer By Layer: 3D Screen Printing And The Future Of Drug Development

  3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.

• Lipid Formulation Development: Why Softgels Are The Technology Of Choice

  Low bioavailability affects roughly 80% of APIs, yet many drug developers default to standard OSD forms. This paper examines why softgels deserve earlier consideration in formulation strategy.

• Rational Design And Material-sparing Strategies For Enabled Intermediates And Drug Products

  A material-sparing strategy integrating formulation mapping, lab-scale spray drying, and compact screening can accelerate risk identification and inform first-round tablet formulation decisions for poorly soluble APIs.

• Blister Solutions

  3/4/2025

  With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

• HPAPI Containment: A Full Lifecycle Safety Innovation

  6/15/2026

  Containing highly potent APIs across a full operational lifecycle requires a structured approach that addresses hazard scoring, quality by design, performance testing, and safe enclosure disposal.

• Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development

  7/24/2026

  Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

• Seamless Commercial Tech Transfers In OSD Manufacturing

  9/9/2026

  A structured approach to OSD tech transfer, from NPI through PPQ and CPV, can compress timelines significantly, as one case study illustrates with full PPQ completion in under six months.

• Delivering API-In-Capsule For Potent, Low-Flow Compounds

  9/9/2026

  See how an automated capsule-filling approach addressed poor-flow APIs, improved operator safety, and supported fast scale-up for clinical supply needs.